UBS Group set a €89.00 ($103.49) price target on Symrise (FRA:SY1) in a research note published on Monday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Several other equities research analysts have also recently issued reports on the stock. Kepler Capital Markets set a €78.50 ($91.28) price objective on shares of Symrise and gave the company a neutral rating in a research report on Tuesday, April 30th. Nord/LB set a €82.00 ($95.35) price target on shares of Symrise and gave the stock a neutral rating in a research report on Thursday, August 8th. Morgan Stanley set a €81.00 ($94.19) price target on shares of Symrise and gave the stock a neutral rating in a research report on Monday, July 15th. Deutsche Bank set a €94.00 ($109.30) price target on shares of Symrise and gave the stock a buy rating in a research report on Wednesday, July 3rd. Finally, Warburg Research set a €89.00 ($103.49) price target on shares of Symrise and gave the stock a neutral rating in a research report on Thursday, August 8th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of Hold and a consensus target price of €81.78 ($95.09).

Symrise stock opened at €80.14 ($93.19) on Monday. Symrise has a 1 year low of €56.96 ($66.23) and a 1 year high of €73.48 ($85.44). The firm has a 50-day moving average of €83.12 and a two-hundred day moving average of €82.30.

About Symrise

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Featured Article: Earnings Reports

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.